1034196-98-9

Basic information

• Product Name: 5-(1,4-Dibenzyl-6-nitro-[1, 4]diazepan-6-yl)-pentanoic acid methyl ester
• Synonyms: 5-(1,4-Dibenzyl-6-nitro-[1, 4]diazepan-6-yl)-pentanoic acid methyl ester
• CAS NO: 1034196-98-9
• Molecular Weight: 439.555
• Mol File: 1034196-98-9.mol
• Article Data: 5

Chemical Properties

• CAS DataBase Reference: 5-(1,4-Dibenzyl-6-nitro-[1, 4]diazepan-6-yl)-pentanoic acid methyl ester(CAS DataBase Reference)
• NIST Chemistry Reference: 5-(1,4-Dibenzyl-6-nitro-[1, 4]diazepan-6-yl)-pentanoic acid methyl ester(1034196-98-9)
• EPA Substance Registry System: 5-(1,4-Dibenzyl-6-nitro-[1, 4]diazepan-6-yl)-pentanoic acid methyl ester(1034196-98-9)

Safety Data

• Hazardous Substances Data: 1034196-98-9(Hazardous Substances Data)

Upstream product

• 50-00-0 formaldehyd 
• 13154-40-0 6-nitrohexanoic acid methyl ester 
• 140-28-3 N,N'-Dibenzylethylenediamine 
• 4883-67-4 2-nitrocyclohexanone 
• 122-75-8 N,N'-dibenzylethylenediamine diacetate 

Downstream Products

• 1579956-44-7 C₂₅H₃₅N₃O₂ 

Relevant articles and documents

[Gd(AAZTA)]? Derivatives with n-Alkyl Acid Side Chains Show Improved Properties for Their Application as MRI Contrast Agents**

Herein, the synthesis and an extensive characterization of two novel Gd(AAZTA) (AAZTA=6-amino-6-methylperhydro-1,4-diazepine tetra acetic acid) derivatives functionalized with short (C2 and C4) n-alkyl acid functions are reported. Th

FLUORESCENT SOLID LIPID NANOPARTICLES COMPOSITION AND PREPARATION THEREOF

The present invention discloses a solid lipid nanoparticle (SLN) comprising: a) a solid lipid core comprising at least a glyceride and/or at least a fatty acid; b) a mixture of amphiphilic components forming a shell around said core a); c) an alkaline-earth complex with a compound of formula I and/or II: d) at least a fluorescent dye selected from: a cyanine fluorescent dye and /or a polyetherocyclic compound selected from: coumarin, pyrano, quinoline, pyranoquinoline, indole and pyranoindole derivates in acid form or a pharmaceutically acceptable salt thereof. These nanoparticles allow a prolonged blood circulation half-life, show enhanced photostability and improved fluorescence signal. The dye is preserved from degradation and improves the fluorescent quantum yield.

A NEW CLASS OF DIAZEPINE DERIVATIVE CHELATING AGENTS AND COMPLEXES WITH PARAMAGNETIC METALS THEREOF AS MRI CONTRAST AGENTS

The present invention relates to a new class of diazepine-derivatives as chel ating agents for paramag netic metal ions, the process for their preparation, and use of such paramagnetic complexes as contrast agents, particularly suitable for Magnetic Resonance Imaging (MRI) analysis.